MedComm | Regulatory T cells: A potential weapon to combat COVID‐19?

2020-08-06

Open the phone and scan

Up to May 27th, there are at least 352 460 patients died from COVID-19, attributed to the widely spread novel coronavirus SARS‐CoV‐2. An effective treatment against COVID-19 is desiderated. Song Guo Zheng et al provided a review focused on the roles of immune cells in pathological processes, and the possiblity of attenuating lung symtoms by activating immunosuppressive T regulatory cells in COVID-19 cases.

Fig. 1 Immune response in lung tissues after coronavirus infection.

 

Article Access: https://onlinelibrary.wiley.com/doi/10.1002/mco2.12

 

 

                                                                           

Website for MedComm: https://onlinelibrary.wiley.com/journal/26882663

Looking forward to your contributions.


Last page：MedComm | Radiomics‐based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS‐CoV‐2) and influenza A infected pneumonia Next page：MedComm | Pulmonary Staphylococcus aureus infection regulates breast cancer cell metastasis via neutrophil extracellular traps (NETs) formation